Ertapenem Resistance of Escherichia coli

Lartigue, Marie-Frédérique; Poirel, Laurent; Poyart, Claire; Réglier-Poupet, Hélène; Nordmann, Patrice

doi:10.3201/eid1302.060747

i

Ertapenem Resistance of Escherichia coli

Supporting Files Public Domain

Feb 2007
By Lartigue, Marie-Frédérique ; Poirel, Laurent ; Poyart, Claire ; ...

Details

Alternative Title:

Emerg Infect Dis
Personal Author:

Lartigue, Marie-Frédérique ; Poirel, Laurent ; Poyart, Claire ; Réglier-Poupet, Hélène ; Nordmann, Patrice
Description:

An ertapenem-resistant Escherichia coli isolate was recovered from peritoneal fluid in a patient who had been treated with imipenem/cilastatin for 10 days. Ertapenem resistance may be explained by a defect in the outer membrane protein and production of extended-spectrum beta-lactamase CTX-M-2.
Subjects:

Anti-Bacterial Agents Antifungal Agents Beta-Lactams Cilastatin Ctx-M Dispatch Drug Combinations Drug Resistance, Multiple, Bacterial Ertapenem Resistance Escherichia Coli Escherichia Coli Infections Extended-Spectrum Β-Lactamase Female Fluconazole Gentamicins Humans Imipenem Immunocompromised Host Middle Aged Outer Membrane Protein Vancomycin
Source:

Emerg Infect Dis. 13(2):315-317.
Document Type:

Journal Article
Volume:

13
Issue:

2
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

urn:sha256:60ba1bbec77cbd2c56e482a1056e2561d472147d428745666218f9d25736d866
Download URL:

https://stacks.cdc.gov/view/cdc/16423/cdc_16423_DS1.pdf
File Type:

[PDF - 59.79 KB ]

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.